阅读说明：本技术 用于肺癌(包括非小细胞肺癌和其他癌症)免疫治疗的新型肽和肽组合物 (Novel peptides and peptide compositions for immunotherapy of lung cancer, including non-small cell lung cancer and other cancers ) 是由 安德里亚·马尔 托尼·温斯切尼克 奥利弗·施尔 延斯·弗里切 哈普瑞特·辛格 克劳迪娅·瓦 于 2016-04-22 设计创作，主要内容包括：本发明涉及用于免疫治疗方法的肽、蛋白质、核酸和细胞。特别是,本发明涉及癌症的免疫疗法。本发明还涉及单独使用或与其他肿瘤相关肽(刺激抗肿瘤免疫反应或体外刺激T细胞和转入患者的疫苗复合物的活性药物成分)联合使用的肿瘤相关T细胞(CTL)肽表位。与主要组织兼容性复合体(MHC)分子结合的肽或与此同类的肽也可能是抗体、可溶性T细胞受体和其他结合分子的靶标。(The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the invention relates to immunotherapy of cancer. The invention also relates to tumor-associated T Cell (CTL) peptide epitopes, used alone or in combination with other tumor-associated peptides that stimulate an anti-tumor immune response or stimulate T cells in vitro and the active pharmaceutical ingredient of the vaccine composition transferred into the patient. Peptides that bind to or are cognate to Major Histocompatibility Complex (MHC) molecules may also be targets for antibodies, soluble T cell receptors, and other binding molecules.)